Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abivax SA - American Depositary Shares
(NQ:
ABVX
)
146.24
+7.89 (+5.70%)
Streaming Delayed Price
Updated: 9:39 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
102,691
Open
140.67
Bid (Size)
145.35 (100)
Ask (Size)
146.63 (100)
Prev. Close
138.35
Today's Range
140.67 - 146.24
52wk Range
4.770 - 142.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year
↗
Today 4:01 EST
A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality.
Via
Stocktwits
Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today
↗
Today 3:45 EST
Markets are moving from a record-setting close into a thin, holiday-shortened Christmas Eve session.
Via
Stocktwits
Topics
ETFs
Stocks
Performance
YTD
+1906.0%
+1906.0%
1 Month
+16.3%
+16.3%
3 Month
+78.3%
+78.3%
6 Month
+2099.1%
+2099.1%
1 Year
+1889.7%
+1889.7%
More News
Read More
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
December 23, 2025
Via
MarketMinute
Topics
Intellectual Property
Why Abivax Stock Was on Fire Today
↗
December 22, 2025
Via
The Motley Fool
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
↗
December 22, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Abivax to be Added to Nasdaq Biotechnology Index
December 18, 2025
From
Abivax
Via
GlobeNewswire
The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
December 18, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 17, 2025
From
Abivax
Via
GlobeNewswire
Abivax Presents Third Quarter 2025 Financial Results
December 15, 2025
From
Abivax
Via
GlobeNewswire
2 Under-the-Radar Stocks That Have Soared This Year
↗
December 09, 2025
Via
The Motley Fool
This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy?
↗
December 09, 2025
Via
The Motley Fool
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?
↗
December 09, 2025
Via
The Motley Fool
Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets
↗
December 09, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
6 Healthcare Stocks With Strong Upward Momentum
↗
November 18, 2025
Via
Benzinga
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover
↗
November 17, 2025
Via
The Motley Fool
This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
November 06, 2025
Via
Benzinga
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
November 03, 2025
From
Abivax
Via
GlobeNewswire
Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday
↗
October 09, 2025
Via
Benzinga
AMD To Rally More Than 47%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
October 07, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
October 06, 2025
Via
Benzinga
Why Is Abivax Stock Trading Higher On Monday?
↗
October 06, 2025
Via
Benzinga
Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease
↗
October 06, 2025
Via
Investor's Business Daily
Topics
Government
Frequently Asked Questions
Is Abivax SA - American Depositary Shares publicly traded?
Yes, Abivax SA - American Depositary Shares is publicly traded.
What exchange does Abivax SA - American Depositary Shares trade on?
Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Abivax SA - American Depositary Shares?
The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
What is the current price of Abivax SA - American Depositary Shares?
The current price of Abivax SA - American Depositary Shares is 146.24
When was Abivax SA - American Depositary Shares last traded?
The last trade of Abivax SA - American Depositary Shares was at 12/24/25 09:39 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
